Skip to content

Neuropsychology of Financial Capacity

Neuropsychology of Financial Capacity

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05791006
Acronym
NEUROFIN
Enrollment
99
Registered
2023-03-30
Start date
2021-08-04
Completion date
2024-11-30
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor, Parkinson Disease, Stroke

Brief summary

The present project aims to investigate the financial capacity in patients diagnosed with Parkinson's Disease or parkinsonism, brain tumor (glioma or meningioma) and cerebrovascular lesion (stroke), in order to evaluate the presence and degree of impairment, and the role of some factors as potential predictors of financial incapacity. The term 'financial capacity' means both operations relating, for example, to asset management or investing money, and activities of daily life such as shopping or using small sums of money; these activities are mediated by different cognitive functions, from numerical and arithmetic skills to decision making. Financial capacity is, in fact, an instrumental activity of daily life (i.e. Instrumental Activity Of Daily Living, I-ADL) whose impairment negatively affects the functional autonomy of the individual, so as to be subject to legal protection. To assess financial capacity, the Numerical Activities of Daily Living - Financial (NADL-F; Arcara et al., 2017) will be administered, a battery of tests aimed at investigating both financial performance and financial competence according to the most recent neuropsychological models proposed in the literature.

Interventions

BEHAVIORALNeuropsychological tests

Neuropsychological assessment with: * NADL-F * Frontal Assessment Battery (FAB) * functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) * Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients * Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients

Sponsors

Istituto Auxologico Italiano
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* age \> 18 years * Clinical diagnosis of interest for clinical groups * For stroke patients: disease duration \> 1 month

Exclusion criteria

* Other brain disorders different from those of interest * Sensory-motor deficits that could prevent neuropsychological assessment * Language disorders that could prevent neuropsychological assessment * Global cognitive impairment as indexed by MoCA \< 26 or MMP \< 22.85

Design outcomes

Primary

MeasureTime frameDescription
Numerical Activity of Daily Living Financial (NADL-F) in Patients with Parkinson's Disease/ParkinsonismsAt baselineAssessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities
Numerical Activity of Daily Living Financial (NADL-F) in Patients with ischemic or haemorrhagic strokeAt baselineAssessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities
Change from baseline in Numerical Activity of Daily Living - Financial (NADL-F)Patients with brain tumorsAt 3 and 12 months follow upAssessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities
Montreal Cognitive Assessment (MoCA)At baselineAssessment of global cognitive functioning
Frontal Assessment Battery (FAB)At baselineAssessment of global cognitive functioning
Activities of daily living questionnaire (ADL)At baselineAssessment of function independence in everyday life

Countries

Italy

Contacts

Primary ContactNadia Bolognini, PhD
n.bolognini@auxologico.it+39025821

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026